These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 4607313

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW, Ribas-Mundo M, Ellison RR, Glidewell O, Lee ST, Cuttner J, Levy RN, Silver R, Blom J, Haurani F, Spurr CL, Harley JB, Kyle R, Moon JH, Eagan RT, Holland JH.
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973 Nov; 43():165-8. PubMed ID: 4531077
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of acute nonlymphoid leukaemia with five different schedules including cytosine arabinoside and 6-thioguanine.
    Mandelli F, Amadori S, De Luca AM, Deriu L, De Rossi G, Isacchi G, Mariani G, Monarca B, Papa G, Di Giovanni F.
    Haematologica; 1977 Apr; 62(2):167-84. PubMed ID: 406174
    [No Abstract] [Full Text] [Related]

  • 12. Childhood cancer: the improving prognosis.
    Sutow WW, Sullivan MP.
    Postgrad Med; 1976 Feb; 59(2):131-7. PubMed ID: 175358
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of the acute leukemias.
    Bernard J, Jacquillat C, Weil M.
    Semin Hematol; 1972 Apr; 9(2):181-91. PubMed ID: 4553226
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The disappearance of ring sideroblasts in myeloblastic leukaemia in remission.
    Shaw MT, Foadi M.
    Scand J Haematol; 1971 Apr; 8(3):177-9. PubMed ID: 5285822
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W, Resegotti L, Rossi M, Infelise V.
    Br Med J; 1973 Sep 15; 3(5880):567-8. PubMed ID: 4516626
    [Abstract] [Full Text] [Related]

  • 17. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Eur J Cancer (1965); 1974 Jul 15; 10(7):413-8. PubMed ID: 4532961
    [No Abstract] [Full Text] [Related]

  • 18. [Cytosine arabinoside in the polychemotherapy of acute leukemia].
    Mandelli F.
    Minerva Med; 1972 Mar 31; 63(24):1436-44. PubMed ID: 4502506
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative results obtained in the treatment of acute lymphoid leukemia, acute myleoid leukemia, and acute monocytoid leukemia.
    Schwarzenberg L, Mathé G, Pouillart P, Weiner R, Hayat M, Amiel JL, Jasmin C, Rosenfeld C, De Vassal F, Schneider M, Cattan A.
    Recent Results Cancer Res; 1973 Mar 31; 43():160-4. PubMed ID: 4531076
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.